These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34376108)

  • 1. The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease.
    Yang X; Ma F; Bai M; Wang Y; Jia Q; Dong R; Liu C; Sun S
    Ren Fail; 2021 Aug; 43(1):1180-1187. PubMed ID: 34376108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.
    Tan L; Tang Y; Peng W; Mathew BS; Qin W
    Kidney Blood Press Res; 2018; 43(4):1333-1343. PubMed ID: 30099439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.
    Ma F; Yang X; Zhou M; Bai M; Zhao L; Li L; Dong R; Liu C; Li R; Sun S
    J Nephrol; 2020 Dec; 33(6):1241-1250. PubMed ID: 32447619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V; Troyanov S; Bellur S; Verhave JC; Cook HT; Feehally J; Roberts IS; Cattran D; Coppo R;
    J Am Soc Nephrol; 2015 Sep; 26(9):2248-58. PubMed ID: 25677392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria.
    Pei G; Tan J; Tang Y; Tan L; Zhong Z; Zhou L; Chen C; Qin W
    Medicine (Baltimore); 2020 Jun; 99(24):e20513. PubMed ID: 32541473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
    Zhong Z; Tang Y; Tan J; Tan L; Pei G; Qin W
    Int Urol Nephrol; 2021 Jan; 53(1):121-127. PubMed ID: 32944888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T; Fitzner C; Eitner F; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JFE; Hilgers RD; Floege J
    J Am Soc Nephrol; 2018 Jan; 29(1):317-325. PubMed ID: 29042456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J; Xu H; Peng Z; Lin L; Li C; Zhu X; Liu S
    Clin Exp Nephrol; 2020 Jan; 24(1):73-81. PubMed ID: 31605314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1.
    Bi X; Yu Y; Zhou S; Zhou Y; Zhao J; Xiong J
    Nephron; 2024; 148(9):587-600. PubMed ID: 38723614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING study.
    Guo Y; Shi S; Zhao J; Wang C; Liu Z; Fu S; Chen N; Li G; Wang L; Ni Z; Zhang H; Lai L; Lv J; Zhang H
    Ren Fail; 2024 Dec; 46(2):2398826. PubMed ID: 39248402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of IgA nephropathy patients with less than 25% crescents and mild proteinuria.
    Jia Q; Ma F; Yang X; Li L; Liu C; Sun R; Li R; Sun S
    Clin Exp Nephrol; 2022 Mar; 26(3):257-265. PubMed ID: 34724588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
    Hou FF; Xie D; Wang J; Xu X; Yang X; Ai J; Nie S; Liang M; Wang G; Jia N;
    JAMA Netw Open; 2023 Feb; 6(2):e2254054. PubMed ID: 36745456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study.
    Rivedal M; Haaskjold YL; Eikrem Ø; Bjørneklett R; Marti HP; Knoop T
    BMC Nephrol; 2024 Jan; 25(1):42. PubMed ID: 38287343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-year GFR slope and long-term renal outcome in IgA nephropathy.
    Lee K; Shin J; Park J; Hwang S; Jang HR; Huh W; Kwon GY; Kim YG; Oh HY; Lee JE; Kim DJ
    Eur J Clin Invest; 2018 Jun; 48(6):e12936. PubMed ID: 29660832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.